DEA GRANTS PHARMACEUTICAL COMPANY MONOPOLY ON MEDICAL CBD
via: BLACKLISTED NEWS BY CAREY WEDLER News circulated recently that the DEA had rescheduled cannabidiol (CBD), the nonpsychoactive ingredient in cannabis, but the technicalities of the agency’s decision actually show their ruling is
read more